Skip to content

Progress Software PRGS Convertible debentures

Convertible debentures at other companies

DexCom logo
DexComDXCM
$0
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$0-100%
Dropbox logo
DropboxDBX
$690.3M+0.2%
Five9 logo
Five9FIVN
$736.37M+0.5%
Nutanix, Inc. logo
Nutanix, Inc.NTNX
$1.35B+0.4%
NTS
Netskope, Inc. Class A Common StockNTSK
$713.32M

Other financials

Income statement

See full
Revenue$247.8M+4.1%
Gross profit$203.9M+6.3%
Operating income$46.5M+43.3%
Net income$22.8M+108%
EPS (diluted)$0.53+121%

Balance sheet

See full
Cash & equivalents$113.2M-8.9%
Total debt$1.3B+76.4%
Total equity$498.8M+15.5%
Total assets$2.4B-2.7%

Cash flow

See full
Operating cash flow$98.6M+43.0%
CapEx$2.7M+110%
Free cash flow$95.9M+41.8%

Valuation

See full
Market cap$1.26B-53.2%
Enterprise value$2.44B-32.9%
P/E14.8×-31.9×
P/S1.3×-1.8×

Profitability

See full
Gross margin81.2%-0.9pp
Operating margin16.9%+1.9pp
Net margin8.6%+1.6pp
FCF margin26.1%+0.8pp

Returns & leverage

See full
Return on equity18.3%+5.6pp
Debt / equity2.6×+0.9×
Current ratio0.5×-0.3×

Where this comes from

Reported directly by Progress Software in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebtNoncurrent.

The official record: Progress Software’s 10-Q, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progress Software's convertible debentures.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progress Software's convertible debentures?
Progress Software (PRGS) reported convertible debentures of $441.66M in Q4 2025.
How has Progress Software's convertible debentures changed year-over-year?
Progress Software's convertible debentures decreased by 44.6% year-over-year, from $797.28M to $441.66M.